ArticleFrontiers in cardiovascular medicine2025
Association of cardiometabolic index with all-cause and cause-specific mortality among overweight and obese adults: a cohort study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The association between composite dietary antioxidant index and sarcopenic obesity.Nutrition & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to explore the associations of cardiometabolic index (CMI) with all-cause and cause-specific mortality among the overweight and obese population. Methods: Mortality data for 13,674 participants with overweight or obesity were sourced from the National Death Index (NDI) and linked to the National Health and Nutrition Examination Survey (NHANES) datasets. We specifically examined the correlations of CMI with all-cause, premature, and cancer mortality. To ensure a comprehensive analysis, various statistical techniques were employed, including the Cox regression model, subgroup and sensitivity analysis, and restricted cubic spline (RCS) regression analysis. We also explored the potential mediating effect of inflammation-related indicators within these associations. Results: After adjusting for all covariates, CMI remained positively associated with all-cause, premature, and cancer mortality among overweight and obese adults. For all-cause mortality, the hazard ratio (HR) was 1.14 [95% confidence interval (CI): 1.01-1.28, Conclusions: Elevated CMI is positively associated with all-cause, premature, and cancer mortality among overweight and obese adults. The associations appeared to be partially mediated by inflammatory pathways, suggesting a mechanism linking CMI to adverse health outcomes. These findings may offer valuable insights for early risk stratification and the formulation of intervention strategies within overweight and obese populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.